Dashboard
Manage Tickers

LUCDLucid Diagnostics Inc.

Nasdaq luciddx.com


$ 0.74 $ 0.01 (1.22 %)    

Friday, 14-Jun-2024 15:57:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 0.748
$ 0.74
$ 0.00 x 0
$ 0.00 x 0
$ 0.74 - $ 0.74
$ 0.63 - $ 1.72
64,683
na
33.67M
$ 1.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-25-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-14-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 04-06-2022 12-31-2021 10-K
11 11-23-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

lucid-diagnostic-reports-4000-firefighter-undergoes-esoguard-esophageal-precancer-testing
Lucid Diagnostic Reports 4,000 Firefighter...
06/12/2024 12:11:26

Firefighter #CheckYourFoodTube Precancer Testing Event organized by Mass General Brigham physicians and Boston Firefighters Loc...

ascendiant-capital-maintains-buy-on-lucid-diagnostics-lowers-price-target-to-75
Ascendiant Capital Maintains Buy on Lucid ...
06/06/2024 17:14:08

Ascendiant Capital analyst Edward Woo maintains Lucid Diagnostics (NASDAQ:LUCD) with a Buy and lowers the price target from ...

cantor-fitzgerald-reiterates-overweight-on-lucid-diagnostics-maintains-3-price-target
Cantor Fitzgerald Reiterates Overweight on...
05/15/2024 12:25:31

Cantor Fitzgerald analyst Ross Osborn reiterates Lucid Diagnostics (NASDAQ:LUCD) with a Overweight and maintains $3 price ta...

needham-reiterates-buy-on-lucid-diagnostics-maintains-25-price-target
Needham Reiterates Buy on Lucid Diagnostic...
05/13/2024 15:50:49

Needham analyst Mike Matson reiterates Lucid Diagnostics (NASDAQ:LUCD) with a Buy and maintains $2.5 price target.

lucids-chairman-and-ceo-says-we-strengthened-balance-sheet-closing-30m-preferred-stock-financing-to-long-term-investors-extends-our-runway-past-milestones-esoguard-commercial-execution-continues-to-deliver-results-as-we-drive-towards-expanded-private-and-public-coverage-as-well-as-direct-contracting
Lucid's Chairman And CEO Says We Strengthe...
05/13/2024 12:08:47

lucid-diagnostics-q1-2024-adj-eps-021-beats-027-estimate-sales-1001m-miss-1046m-estimate
Lucid Diagnostics Q1 2024 Adj EPS $(0.21) ...
05/13/2024 12:03:45

Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0...

Core News & Articles
Lucid Diagnostics Says EsophaCap Device Re...
05/09/2024 12:23:10

Core News & Articles
Lucid Diagnostics Announces Peer-Reviewed ...
05/02/2024 11:54:18

EsoGuard demonstrated unprecedented early precancer detection, including 89% sensitivity at detecting short segment early preca...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 16:31:18

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/29/2024 20:31:14

needham-reiterates-buy-on-lucid-diagnostics-maintains-25-price-target
Needham Reiterates Buy on Lucid Diagnostic...
04/12/2024 08:37:23

Needham analyst Mike Matson reiterates Lucid Diagnostics (NASDAQ:LUCD) with a Buy and maintains $2.5 price target.

cantor-fitzgerald-maintains-overweight-on-lucid-diagnostics-lowers-price-target-to-3
Cantor Fitzgerald Maintains Overweight on ...
03/27/2024 14:05:45

Cantor Fitzgerald analyst Ross Osborn maintains Lucid Diagnostics (NASDAQ:LUCD) with a Overweight and lowers the price targe...

needham-reiterates-buy-on-lucid-diagnostics-maintains-25-price-target
Needham Reiterates Buy on Lucid Diagnostic...
03/27/2024 09:20:42

Needham analyst Mike Matson reiterates Lucid Diagnostics (NASDAQ:LUCD) with a Buy and maintains $2.5 price target.

lucid-diagnostics-q4-eps-023-beats-026-estimate-sales-104m-miss-105m-estimate
Lucid Diagnostics Q4 EPS $(0.23) Beats $(0...
03/25/2024 21:43:59

Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0...

Core News & Articles
Lucid Diagnostics Provides Business Update...
03/25/2024 21:33:22

Lucid Diagnostics had cash and cash equivalents of $18.9 million as of December 31, 2023, compared to $22.5 million as of Decem...

earnings-scheduled-for-march-25-2024
Earnings Scheduled For March 25, 2024
03/25/2024 09:33:46

Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on re...

earnings-preview-lucid-diagnostics
Earnings Preview: Lucid Diagnostics
03/22/2024 14:01:32

Core News & Articles
Lucid Diagnostics Announces Data From The ...
03/21/2024 13:31:09

Prospective VA screening study demonstrates excellent EsoGuard sensitivity of 92.9% and negative predictive value of 98.6% comp...

lucid-diagnostics-announces-multiple-presentations-at-digestive-disease-week-2024-conference
Lucid Diagnostics Announces Multiple Prese...
03/20/2024 12:44:32

Lucid and collaborators will present data on three studies on EsoGuard® esophageal precancer testing and one on a new genetic c...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
02/19/2024 21:30:44

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)